论文部分内容阅读
目的探讨卡维地洛在心肌梗死后左心功能不全的应用效果。方法将70例心肌梗死后合并左心功能不全的患者按照就诊顺序随机分为对照组和观察组各35例。其中对照组予常规内科治疗,观察组同时加用卡维地洛,观察并比较2组的临床治疗效果。结果观察组患者总有效率为97.14%,显著高于对照组的74.29%(P<0.05);治疗后2组患者超声心动图LVEF、LVEDD和LVESD指标均较治疗前明显改善(P<0.05),且观察组改善幅度明显优于对照组(P<0.05);治疗后2组患者心功能均有明显改善(P<0.05),且观察组心功能明显优于对照组(P<0.05)。结论卡维地洛应用于心肌梗死后左心功能不全的患者可显著改善其心功能,极具临床应用和推广价值。
Objective To investigate the effect of carvedilol on left ventricular dysfunction after myocardial infarction. Methods Seventy patients with myocardial infarction complicated with left ventricular dysfunction were randomly divided into control group and observation group according to the order of treatment. The control group was given conventional medical treatment. The observation group was given carvedilol at the same time. The clinical effects of the two groups were observed and compared. Results The total effective rate in observation group was 97.14%, which was significantly higher than that in control group (74.29%, P <0.05). The echocardiographic LVEF, LVEDD and LVESD indexes of two groups were significantly improved after treatment (P <0.05) (P <0.05). The improvement of the observation group was significantly better than that of the control group (P <0.05). After treatment, the cardiac function of the two groups was significantly improved (P <0.05), and the cardiac function of the observation group was significantly better than that of the control group (P <0.05). Conclusion Carvedilol used in patients with left ventricular dysfunction after myocardial infarction can significantly improve their cardiac function, great clinical application and promotion of value.